Single Application Brachytherapy in Cervical Cancer
NCT03110497 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2018-11-07
Summary
The purpose of the study is to evaluate safety and feasibility of single brachytherapy application with dose delivery in multiple fractions. Study will be conducted in Phase I/II clinical trial setting with strict Image guidance protocol.This study is expected reduce treatment duration and to increase ease and acceptability of brachytherapy in patients along with significant saving of resources
Conditions
Interventions
- RADIATION
-
Single application multi-fraction brachytherapy
Single application brachytherapy procedure to deliver high dose rate fractions of 9Gy, 7Gy and 7Gy with 6-12 hours apart under strict image guidance
Sponsors & Collaborators
-
Tata Memorial Hospital
lead OTHER_GOV
Principal Investigators
-
Umesh Mahantshetty, MD, DNB · Professor, Department of Radiation oncology, Tata memorial Centre, Mumbai
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-17
- Primary Completion
- 2019-04-17
- Completion
- 2020-04-17
Countries
- India
Study Locations
More Related Trials
-
Spatially Fractionated Radiation Treatment for Gynaecological Cancers
NCT06644846 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy or Chemoradiation, Interstitial Brachytherapy in Combination With Hyperthermia in Advanced Cervical Cancer
NCT03249519 ·Status: RECRUITING ·Phase: NA
-
Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer
NCT06149767 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Hypofractionated Radiochemotherapy
NCT06331468 ·Status: RECRUITING ·Phase: PHASE2
-
High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix
NCT00193830 ·Status: COMPLETED ·Phase: PHASE3
-
Radiosensitizing Effect of Nelfinavir in Locally Advanced Carcinoma of Cervix
NCT03256916 ·Status: COMPLETED ·Phase: PHASE3
-
Chemo-radio-immunotherapy With Nivolumab and Ipilimumab Treatment in Locally Advanced Cervical Cancer Patients
NCT05504642 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
NCT00104910 ·Status: COMPLETED ·Phase: PHASE1
-
Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.
NCT06128460 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Niraparib Combined With Brivanib or Toripalimab in Patients With Cervical Cancer
NCT04395612 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer
NCT05105672 ·Status: UNKNOWN ·Phase: PHASE2
-
Reducing Radiation Target Volume for Stage IIb Cervical Cancer
NCT07249957 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Irinotecan Study For Cervical Cancer
NCT00136955 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Trial Comparison of 3 vs 4 Fractions (BRACHY-FIT).
NCT07022470 ·Status: RECRUITING ·Phase: PHASE2
-
Palliative Radiation for Advanced Cervical Cancer
NCT03997110 ·Status: RECRUITING ·Phase: NA
-
Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma
NCT01554410 ·Status: COMPLETED ·Phase: PHASE1
-
Nasopharyngeal Carcinoma Post IMRT
NCT02597426 ·Status: ACTIVE_NOT_RECRUITING
-
A Trial Comparing Intensity Modulated Radiation Therapy (IMRT) With Conventional Radiation Therapy in Stage IIB Carcinoma Cervix
NCT00193804 ·Status: COMPLETED
-
Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
NCT00003078 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy and Pelvic Hypofractionated Radiation Followed by Brachytherapy for Cervical Cancer
NCT04070976 ·Status: RECRUITING ·Phase: NA
-
Phase III Study of S-1 + Cisplatin vs Cisplatin in Cervical Cancer
NCT00770874 ·Status: COMPLETED ·Phase: PHASE3
-
A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients
NCT00340184 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Response and Toxicity of Hypo-fractionated Chemoradiotherapy in Cervix Cancer
NCT04831437 ·Status: RECRUITING ·Phase: PHASE2
-
Magnetic Resonance Imaging-Based Radiation Therapy and Cisplatin in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer
NCT01016561 ·Status: TERMINATED ·Phase: NA
-
Individualized Precise Radiotherapy With the Guidance of Radiosensitivity of Locally Advanced Cervical Cancer
NCT03163979 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3